Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: New J Chem. 2019 Nov 28;44(2):338–345. doi: 10.1039/c9nj05336k

Triptycene Walled Glycoluril Trimer: Synthesis and Recognition Properties

Sandra Zebaze Ndendjio a, Wenjin Liu a,b, Nicolas Yvanez a,c, Zihui Meng b, Peter Y Zavalij a, Lyle Isaacs a
PMCID: PMC8049523  NIHMSID: NIHMS1061595  PMID: 33867799

Abstract

We report the synthesis of a new acyclic CB[n]-type host (1) that features a central glycoluril trimer capped by triptycene sidewalls. Host 1 has good solubility in water (≈ 3 mM) and does not undergo strong self-association (Ks = 480 M−1). We probed the geometry of the complexes by analyzing the complexation induced changes in the 1H NMR spectra and measured the complexation thermodynamics by isothermal titration calorimetry. The conformation of 1 and its packing in the solid state was revealed by single crystal x-ray diffraction measurements.

Introduction

The synthesis and molecular recognition properties of the cucurbit[n]uril (CB[n]) family of molecular container compounds has undergone rapid development since the turn of the millennium.1 Figure 1 shows the molecular structure of CB[n] which are composed of n glycoluril units connected by 2n methylene bridges that form a barrel shaped macrocycle with two electrostatically negative ureidyl carbonyl fringed portals and a central hydrophobic cavity. Accordingly, macrocyclic CB[n] bind tightly to hydrophobic (di)ammonium ions in water with binding constants typically in the 106 – 1012 M−1 range, even exceeding 1017 M−1 in special cases.2 The very high affinity of CB[n]•guest complex has been traced, in part to the presence of intracavity waters that lack a full complement of H-bonds that are released upon complexation.3 Accordingly, the Ka values for CB[n]•guest complexes have been featured prominently in a series of blinded challenges (SAMPL and Hydrophobe) that aim to improve computational approaches to free energy calculations in water.4 CB[n]•guest complexes respond sensitively to appropriate stimuli (e.g. pH, chemical, electrochemical, photochemical)5 allowing them to be used as a high fidelity switching element in complex systems. Accordingly, unfunctionalized macrocyclic CB[n] has found numerous uses including as a component of (bio)sensing ensembles,6 for drug formulation, delivery and sequestration,7 to create supramolecular organic frameworks,8 and to perform supramolecular catalysis.3c With the development of functionalized CB[n], the range of application has been expanded to include CB[n] based targeted drug delivery and theranostics, materials for protein capture, supramolecular Velcro, and nanoparticle based optical assays.9

Figure 1.

Figure 1

Structure of CB[n] (n = 5, 6, 7, 8, 10, 14), acyclic CB[n]-type receptor M1, and DimerTrip.

In recent years, we and others have been studying acyclic CB[n]-type receptors that feature a central glycoluril oligomer (e.g. dimer – tetramer) that is capped by aromatic sidewalls.10a, 10b, 1d, 10c, 10d Figure 1 shows the structure of the prototypical acyclic CB[n] (M1) which features a central glycoluril tetramer, o-xylylene sidewalls, and sulfonate solubilizing groups. M1 shows excellent biocompatibility according to a variety of in vitro and in vivo assays11 and is therefore considered for real world applications. For example, M1 and analogues have been used as solubilizing excipients for insoluble drugs,12 for pH triggered delivery agents,13 as in vivo sequestration agents for neuromuscular blockers and drugs of abuse,14 and as components of sensing arrays.15 Most recently, we have created chimeric receptors comprising glycoluril monomer, dimer, or tetramer units with triptycene sidewalls with the goal of increasing binding capacity and binding strength and observed interesting behavior like triggered decomposition of vesicles and the ability to wrap around macrocyclic guests.16 In this paper we prepare acyclic CB[n]-type host 1 derived from glycoluril trimer, investigate its binding properties toward alkylammonium ions to elucidate its basic recognition properties and to serve as a blinded dataset for the SAMPL7 challenge,17 and finally to assess its potential as as a sequestration agent toward drugs of abuse.

Results and Discussion

This results and discussion section is organized as follows. First, we present the design, synthesis, and characterization of host 1. Next, we quantify the self-association propensity of 1 and perform qualitative 1H NMR based host•guest complexation studies. Subsequently, we measure the complexation thermodynamic parameters by isothermal titration calorimetry (ITC) and discuss the observed structure-binding constant trends.

Design, Synthesis, and Characterization of Host 1.

The synthesis of host 1 is based on our previously described building block approach1d involving the electrophilic aromatic substitution reactions between glycoluril bis(cyclic ethers) and activated aromatic rings. Accordingly, we reacted glycoluril trimer 218 with triptycene derivative 316c under acidic conditions (TFA, Ac2O) which delivered crude 1 after precipitation with EtOH. Purification of 1 was challenging and required a combination of washing with EtOH and acetone followed by recrystallization from mixtures of EtOH and H2O to deliver 1 in 4.4% isolated yield. The chemical structure of 1 was fully elucidated by spectroscopic means and was further confirmed by single crystal x-ray diffraction studies (vide infra). The 1H NMR spectrum of 1 in D2O shows a single resonance for the glycoluril methine protons (Hj), two pairs of resonances for the diastereotopic methylene bridges (Hf,g and Hh,i), two CH3-groups (k and l), and two pairs of aromatic protons (Ha,b and Hc,d). The number of resonances is fully consistent with the time-averaged C2v-symmetry depicted in Figure 2. However, the resonance for Hb on the tip of the aromatic ring is upfield shifts and appears at 5.7 ppm which suggests that uncomplexed 1 assumes a self-folded conformation in water (vide infra) similar to previously prepared triptycene walled glycoluril tetramer.16c The 13C NMR spectrum for 1 recorded in DMSO-d6 displays 22 resonances which is also in agreement with time averaged C2v-symmetry. Finally, the high resolution ESI-MS spectrum of 1 shows a doubly charged ion at m/z 829.20204 which is in accord with the calculated value (C76H75N12NaO22S4, [M + 1H − 3Na]2−, calculated 829.19495).

Figure 2.

Figure 2

Synthesis of host 1.

Self-Association Properties of Host 1.

Before proceeding to investigate the host•guest properties of 1 we perform dilution studies to quantify the extent of self-association of 1.19 Accordingly, we measured the 1H NMR spectra of a series of solutions of 1 in D2O from its solubility limit of 3 mM down to 0.05 mM (Figure S4). We observe small changes in chemical shift of many protons including Hb, Hk/l, and Hf. Figure 4 shows a plot of the concentration of 1 versus chemical shift of Hb that was fitted to a dimerization model in Scientist™ (Supporting Information) which allowed us to extract the self-association constant (Ks = 480 ± 81 M−1). The measurement of the thermodynamic parameters of complexation of 1 (vide infra) were measured by ITC at [1] = 100 μM where the host remains monomeric.

Figure 4.

Figure 4

Plot of chemical shift of Hb versus [1] used to determine the self-association constant Ks = 480 ± 81 M−1 for 1.

X-ray Crystal Structure of 1.

We were fortunate to obtain single crystals of 1 by recrystallization from mixtures of EtOH and H2O and to solve its structure by x-ray crystallography (CCDC-1949769). Figure 5a and 5b show stereoscopic representations of the two independent molecules of 1 in the crystal. The molecule of 1 in Figure 5a is C2-symmetric and features an out-of-plane helical distortion that renders it chiral. Similarly, the molecule of 1 in Figure 5b is skewed out-of-plane and is therefore chiral; it also includes a solvating CF3CO2H molecule. Interestingly, only one sense of handedness is present in the crystal structure of 1 and therefore the crystal is a conglomerate. Figure 5c shows a stereoview of how these two different molecules of 1 pack next to each other in the crystal. The external face of the triptycene unit of one molecule of 1 embraces the convex face of the glycoluril region of the adjacent molecule of 1 and vice versa. The fact that two different conformations were observed in the crystal and the 1H NMR evidence of a π-stacked conformation presented above highlights the conformational flexibility of the acyclic CB[n] that enables it to bind to a wide variety of guests.20

Figure 5.

Figure 5

Cross-eyed stereoviews of the crystal structure of 1. a&b) Two independent molecules of 1. c) Packing of the two independent molecules of 1 into a dimeric unit. Color code: C, grey; H, white; N, blue; O, red; S, yellow; F, green.

Qualitative 1H NMR Host•Guest Recognition Study.

Next, we decided to perform a qualitative investigation of host•guest binding of 1 toward guests 419 (Figure 6) by 1H NMR spectroscopy (Supporting Information). For example, Figure 3ac shows the 1H NMR spectra recorded for uncomplexed 8, and 1:1 and 1:2 mixtures of 1 with 8. As expected, the resonances for guest protons Hr, Hs, and Ht undergo substantial upfield shifts (> 1.5 ppm) upon formation of the 18 complex reflecting the encapsulation of the hydrophobic octylene chain inside the hydrophobic cavity of the host defined by the four aromatic rings of the triptycene sidewalls. The resonance for Hq also shifts significantly upfield (0.95 ppm) probably due to a helical twisting of 1 in the complex which deepens the cavity and brings Hq into proximity of a triptycene sidewall. The presence of separate resonances for free guest 8 and bound guest 8 (Figure 3b) at a 1:2 1:8 stoichiometry reflects the slow kinetics of host•guest exchange on the chemical shift timescale. Host 1 also undergoes significant changes in chemical shift upon formation of the 18 complex. For example, the triptycene bridgehead methine resonance (He) moves downfield by 0.3 ppm. Most significantly, however, the resonance for Hb undergoes a substantial downfield shift (≈ 1.78 ppm) upon complexation which indicates that guest binding unfolds the self-folded conformation described above. Similar qualitative binding studies were performed for the remainder of the guests. In accord with expectations, we find that the resonances for the hydrophobic regions of guests 4-19 undergo substantial upfield shifts upon complexation due to the shielding effect of the triptycene sidewalls. The complexes of 1 with guests 510, 12, 13, 16, 17, and 18 display slow to intermediate exchange kinetics (e.g. two sets of broadened resonances) on the NMR timescale whereas guests 4, 11, 1415, and 1926 display intermediate to fast (e.g. one set of broadened resonances) kinetics of exchange.

Figure 6.

Figure 6

Structures of guests 426 used in this study.

Figure 3.

Figure 3

1H NMR spectra recorded (600 MHz, RT, 20 mM sodium phosphate buffered D2O, pH 7.0) for: a) guest 8 (2 mM), b) a mixture of 1 (250 µM) and 8 (500 µM), c) a mixture of 1 (250 µM) and 8 (250 µM), and d) host 1 (250 µM).

Measurement and Discussion of the Thermodynamic Parameters of Complex Formation.

After qualitatively assessing the host•guest binding properties of 1 we decided to quantify the binding constants (Ka, M−1). Given that CB[n]•guest binding constants typically exceed the dynamic range of 1H NMR we decided to use ITC to simultaneously measure Ka and ΔH; ITC experiments were conducted in duplicate. For example, Figure 7a shows the thermogram recorded when a solution of 1 (100 μM) in the ITC cell was titrated with a solution of pentane diammonium 5 (1 mM) in the syringe. Figure 7b shows the fitting of the integrated heat values to a 1:1 binding model with Ka = 1.33 × 106 M−1 and ΔH = −8.58 kcal mol−1. For the 1•guest values with Ka ≤ 4.08 × 106 M−1 reported in Table 1 we performed similar direct ITC titrations. For complexes with higher Ka values, and therefore c-values that exceed the recommended range,21 we turned to competitive ITC titrations. In competition ITC, a solution of the host and an excess of a weaker binding guest is titrated with a solution of the tighter binding guest. Using the known concentrations of host, weak guest, and host•weak guest Ka and ΔH as inputs allowed us to fit the thermogram to a competitive binding model in the PEAQ-ITC data analysis software to extract the thermodynamic constants for the tighter host•guest complexes reported in Table 1 (Supporting Information).

Figure 7.

Figure 7

a) ITC thermogram recorded during the titration of host 1 (100 μM) in the cell with guest 5 (1.0 mM) in the syringe, b) Fitting of the data to a 1:1 binding model with Ka = 1.33 × 106 M−1.

Table 1.

Binding constants (Ka, M−1) and binding enthalpies (ΔH, kcal mol−1) measured for 1•guest. Binding constants (Ka, M−1) measured for DimerTrip•guest, and M1•guest complexes (298 K, 20 mM NaH2PO4 buffered water, pH 7.4).

G 1 DimerTrip / M1 f
4 (2.92 ± 0.257) × 104 a
−6.03 ± 0.260
DT: (4.47 ± 0.75) × 103
5 (1.33 ± 0.0308) × 106 a
−8.58 ± 0.021
DT: (1.23 ± 0.05) × 105
6 (2.29 ± 0.166) × 107 c
−10.8 ± 0.044
DT: (8.81 ± 0.59) × 105
M1: (5.05 ± 0.31) × 107
6DQ (5.00 ± 0.209) × 107 c
−12.7 ± 0.028
DT: (1.26 ± 0.09) × 106
M1: (8.93 ± 0.33) × 107
6Q (1.20 ± 0.0329) × 106 a
−8.54 ± 0.027
DT: (3.41 ± 0.5) × 104
M1: (1.24 ± 0.06) × 106
7 (7.24 ± 0.702) × 107 c
−10.1 ± 0.036
DT: (7.11 ± 0.32) × 105
8 (1.41 ± 0.195) × 108 d
−11.5 ± 0.094
DT: (6.27 ± 0.41) × 105
9 (2.42 ± 0.334) × 108 d
−11.4 ± 0.062
DT: (5.23 ± 0.34) × 105
10 (2.81 ± 0.507) × 108 e
−11.3 ± 0.068
DT: (3.7 ± 0.16) × 105
12 (4.55 ± 0.943) × 108 d
−10.4 ± 0.064

11 (3.57 ± 0.139) × 105 a
−4.83 ± 0.036

M1: (1.73 ± 0.20) × 107
13 (1.13 ± 0.109) × 107 a
−10.1 ± 0.119
DT: (1.04 ± 0.16) × 104
M1: (1.70 ± 0.05) × 107
14 (4.08 ± 0.341) × 106 a
−7.41 ± 0.084

15 (1.11 ± 0.0743) × 106 a
−5.88 ± 0.049

16 (8.77 ± 0.493) × 106 c
−10.5 ± 0.044
DT: (7.1 ± 0.23) × 104
M1: (1.67 ± 0.08) × 108
17 (5.81 ± 0.443) × 107 c
−12.4 ± 0.045

M1: (4.69 ± 0.22) × 108
18 (3.57 ± 0.185) × 108 d
−13.7 ± 0.039

19 (5.95 ± 0.222) × 104 a
−6.61 ± 0.088
DT: (3.29 ± 0.71) × 103
M1: (1.95 ± 0.09) × 106
20 (1.33 ± 0.0414) × 107 c
−14.7 ± 0.036

M1: (1.1± 0.04) × 107
21 (9.80 ± 0.317) × 104 a
−5.09 ± 0.042

M1: (4.7 ± 0.5) × 104
22 (5.61 ± 0.583) × 104 b
−3.98 ± 0.0942

23 (8.47 ± 3.10) × 103 a
−4.95 ± 2.30

M1: (1.1 ± 0.1) × 104
24 (9.43 ± 0.198) × 105 a
−9.63 ± 0.025

M1: (7.5 ± 2.9) × 106
25 (3.70 ± 0.111) × 104 a
−9.99 ± 0.129

M1: (6.6 ± 0.4) × 105
26 (4.67 ± 0.446) × 103 b
−8.92 ± 0.445

M1: 1.8 × 105
a

Measured by direct ITC titration of host (100 μM) in the cell with guest (1 mM) in the syringe.

b

Measured by direct ITC titration of host (200 μM) in the cell with guest (>1 mM) in the syringe.

c

Measured by ITC competition assay using 19 (0.5 mM) as competitor included in the cell.

d

Measured by ITC competition assay using 5 (0.5 mM) as competitor included in the cell.

e

Measured by ITC competition assay using 5 (0.2 mM) as competitor included in the cell.

f

Data drawn from literature references.14b, 16a, 22

Magnitude of Binding Constants and Enthalpies.

A perusal of Table 1 reveals that the Ka values for 1 with guests 419 fall in the range of 4670 – 4.55 × 108 M−1; this large dynamic range of Ka values is desirable given their use as the blinded dataset in the upcoming SAMPL7 challenge. The complexes are all driven by favorable enthalpic contributions with ΔH values ranging from −3.98 to −14.7 kcal mol−1. The substantial enthalphic driving forces observed are not unexpected given that cavity bound waters that lack a full complement of H-bonds are known to provide an enthalpic driving force for the complexes of macrocyclic CB[n].3

Influence of Diammonium Ion Length.

CB[6] is known to preferentially bind to diammonium ions whose length (e.g. H3N+•••NH3+) matches the C=O•••O=C distances of the host; CB[6]•5 and CB[6]•6 display maximal affinity.2a An examination of Table 1 reveals a very different trend in Ka with the Ka values for increasing steadily from 14 (2.92 × 104 M−1) to 18 (1.41 × 108 M−1) and then plateaus at ≈ 108 M−1 for longer diammonium ions 9, 10, and 12. Host 1 can accommodate longer diamines because it can flex and expand its cavity and because the (CH2)3SO3 arms deepen the cavity while providing for new ammonium•••sulfonate interactions. Similar observations have been made previously for a carboxylate analogue of M1.23

Drugs of Abuse.

Recently, we have found that acyclic CB[n]-type receptors (e.g. M1) bind tightly to neuromuscular blocking agents and function as in vivo reversal agents.14a, 11b, 11c More recently, we found that acyclic CB[n] bind strongly to methamphetamine and fentanyl and modulate the hyperlocomotion induced by methamphetamine in vivo (rats).14b Accordingly, we decided to determine the binding affinities of 1 toward a panel of drugs of abuse (2026) by ITC (Table 1). Most notable is the interaction between 1 and fentanyl with Kd = 75 nM which makes it suitable as a potential in vivo reversal agent. The interaction between 1 and 2126 are substantially weaker (Ka < 106 M−1). The data in Table 1 also allow a comparison between 1 and M1. As can be seen, M1 is often a slightly stronger host than 1, most notably toward methamphetamine. This trend is not unexpected given that acyclic CB[n] based on glycoluril tetramer have more fully formed ureidyl C=O portals and larger cavities.18

Influence of Guest Charge.

Compounds 6DQ and 6Q differ in the number of quaternary ammonium ions while maintaining a common hexylene hydrophobic core. Table 1 shows that the complex between 1 and dicationic guest 6DQ (Ka = 5.00 × 107 M−1) is 42-fold stronger than 1•6Q (Ka = 1.20 × 106 M−1). Similar, but more pronounced trends are seen for CB[n]•guest complexes where an additional ion-dipole interaction commonly increases Ka by 102-103 M−1.5b, 24

Influence of the Cationic Headgroup.

Compounds 6 and 6DQ as well as 11 and 13 differ only in the presence of primary ammonium (NH3+) or quaternary ammonium (NMe3+) ion centers. Table 1 shows that 1 binds the quaternary guests (6DQ and 13) more tightly by 2.2-fold and 31.7-fold. Related effects have been seen for macrocyclic CB[7] complexes where the magnitude of the effect is dependent on the nature of the hydrophobic moiety.2b, 25, 2e

Influence of Guest Hydrophobic Residue.

Macrocyclic CB[n]•guest complexes are very sensitive to the size and shape of the guest because the cavity of these hosts cannot easily expand its size to alleviate steric interactions.2a, 2b For example, CB[7] binds 11 (Ka = 4.23 × 1012 M−1) more that 108-fold stronger than 3,5-dimethyladamantaneamine (memantine, Ka = 25000 M−1).2b Consider the following series of guests: 6, 16, 17, 18, and 15. Across this series, there is a constant number of C-atoms (6) in between the two ammonium ions centers. However, the total number of C-atoms in the hydrophobic moiety of the guest (6: 6; 16: 8, 17: 10, 18: 10, and 15: 14) and the nature of hydrophobicity of the moiety (e.g. aromatic 16 and 17 versus aliphatic 6, 18, 15). As the number of C-atoms of the guest is increased one would expect larger Ka values due to more favorable desolvation of the larger guests upon complexation. Conversely, as the size and cross-sectional area of the hydrophobic guest moiety is increased beyond an optimum one might expect decreased Ka values due to energetically costly expansion of the host cavity. Within this series of guests we observe a maximum Ka value of (3.57 ± 0.185) × 108 M−1 for 118. As expected, the bulky multicyclic guests 21, 22, and 26 are quite poor guests for 1 with Ka in the 104 – 105 M−1 range.

Comparisons between Hosts.

Table 1 also presents the binding constants of two related hosts (M1 and DimerTrip) drawn from the literature.14b, 16a, 22 DimerTrip is an analogue of 1 that only contains two glycoluril rings. Accordingly, the cavity of DimerTrip is CB[6] sized and therefore smaller than the cavity of 1. A comparison of the binding constants given in Table 1 reveals that 1 is a superior host compared to DimerTrip by 6.5 to 1086-fold. The highest selectivities are seen for bulky guests (13: 1086-fold; 10: 760-fold) which cannot be fully encapsulated inside DimerTrip without substantial energetic penalties for cavity expansion. M1 differs from 1 by the number of glycolurils (4 versus 3) unit and by the different sidewalls (benzene versus triptycene). A comparison of the Ka values in Table 1 toward a given guest shows that M1 and 1 are comparable hosts in many cases (e.g. 6, 6DQ, 6Q, 13, 20). Interestingly, host M1 binds significantly stronger than 1 toward 11 (49-fold), 16 (19-fold), 17 (8-fold), and 24 (8-fold). Guests 16, 17, and 24 all contain aromatic ring binding sites which suggests that the hydrophobic box defined by M1 is more appropriate for simultaneous edge-to-face and offset π-stacking with guests.12 We conclude that 1 is a surprisingly good host that is nearly on par with the prototypical acyclic CB[n]-type receptor M1.

Conclusions

In summary, we have reported the synthesis of host 1 which is based on a central glycoluril trimer capped with two triptycene sidewalls. Host 1 is water soluble (3 mM) and does not undergo strong self-association in water (Ks = 480). In solution, 1 displays upfield chemical shifts for Hb of the triptycene sidewall (Figure 3d) which indicates a self-folded conformation. In constrast, the x-ray crystal structure of 1 displays two more open conformations where the triptycene sidewalls undergo an out-of-plane helical distorsion. In combination the 1H NMR and x-ray results highlight the high conformational flexibility of 1 which stands in constrast to macrocyclic CB[n]. The geometries and thermodynamics of complexation between 1 and guests 426 were elucidated by 1H NMR induced chemical shifts and measured by ITC. A subset of these Ka values form the blinded dataset for the SAMPL7 challenge.17 We find that host 1 with its central glycoluril trimer is a superior host compared to previously synthesized host DimerTrip. Host 1 even displays Ka values toward many guests that are very close to those measured for M1 which is the prototypical acyclic CB[n]-type host. Finally, host 1 is a powerful receptor for fentanyl which suggests its potential application as an in vivo sequestration agent.

Experimental.

General Experimental.

Starting materials were purchased from commercial suppliers and used without further purification or were prepared by literature procedures.18, 16c Melting points were measured on a Meltemp apparatus in open capillary tubes and are uncorrected. IR spectra were recorded on a JASCO FT/IR 4100 spectrometer and are reported in cm−1. NMR spectra were measured on commercial instruments operating at 400 or 600 MHz for 1H and 100 or 150 MHz for 13C using D2O or DMSO-d6 as solvents. Chemical shifts (δ) are referenced relative to the residual resonances for HOD (4.80 ppm) and DMSO-d6 (2.50 ppm for 1H, 39.51 ppm for 13C). Mass spectrometry was performed using a JEOL AccuTOF electrospray instrument (ESI). ITC data were collected on a Malvern Microcal PEAQ-ITC instrument.

Host 1.

A mixture of 2 (620 mg, 1.01 mmol) and 3 (1.332 g, 2.32 mmol) was dissolved in TFA/Ac2O (1:1 (v:v), 40 mL). The solution was stirred under N2 at 90 ˚C for 3.5 h and then was cooled to room temperature. EtOH (300 mL) was added to the reaction and the heterogenous mixture was stirred for 1 h. The precipitate was obtained by centrifugation and dried under high vacuum to obtain the crude product. The crude product was washed with EtOH (3 × 100 mL) and acetone (3 × 100 mL). After drying overnight, the crude product (300 mg) was recrystallized from H2O/EtOH (1:10). The solid was dissolved in a minimal amount of water and the pH was adjusted to 7 with 1 mM NaOH. A red precipitate was observed and collected by centrifuged. The precipitate was dried and dissolved in a minimal amount of water and the pH was adjusted to 1 with 1mM HCl. The solid was dried and recrystallized from H2O/EtOH (1:2). A thin white precipitate was observed very quickly and was gently collected by decantation. The solid was then dried under high vacuum overnight to give host 1 as a white powder (77.5 mg, 4.4% yield). M.p. >300 ˚C. 1H NMR (600 MHz, D2O, RT): δ 7.59 (s, 4H), 7.12 (s, 4H), 6.83 (s, 4H) 5.73 (s, 4H), 5.67 (s, 4H), 5.45 (d, J = 15.6, 4H), 5.32 (s, 2H), 5.04 (s, 4H), 4.20 (d, J = 16.4, 4H), 4.14 (d, J = 15.6, 8H), 3.91 (s, 4H), 3.24 (m, 8H), 2.37 (m, 8H), 1.73 (s, 6H), 1.65 (s, 6H). 1H NMR (600 MHz, DMSO-d6, RT): δ 7.48 (m, 8H), 7.15 (m, 4H), 6.98 (m, 4H), 5.79 (s, 4H), 5.44 (d, J = 15.2, 6H), 5.03 (d, J = 16.3, 4H), 4.07 (m, 12H), 3.82 (d, J = 7.2, 4H), 2.89 (m, 8H), 2.22 (m, 8H), 1.71 (s, 6H), 1.58 (s, 6H). 13C NMR (600 MHz, D2O, 1,4-dioxane as internal reference, RT): δ 155.5, 146.9, 144.1, 142.8, 139.1, 125.3, 124.4, 123.5, 122.9, 77.9, 76.9, 73.9, 70.9, 66.1, 56.9, 48.2, 47.5, 47.4, 35.3, 24.6, 16.2, 14.6. IR (ATR, cm−1): 3574m, 2918w, 1614s, 1427s, 1027m, 877s, and 701s. HR-MS (ESI-MS negative) m/z 829.20204 ([M + 1H − 3Na]2−), calculated 829.19495.

Supplementary Material

Supporting Information

Acknowledgements.

We thank the National Science Foundation (CHE-1404911 and CHE-1807486) and the National Institutes of Health (GM-132345 and GM-124270) for financial support.

Footnotes

Electronic Supplementary Information (ESI) available: Details of synthesis, NMR, and ITC experiments. See DOI: 10.1039/x0xx00000x

Conflicts of interest

L.I. is an inventor on patents held by the University of Maryland on the use of acyclic CB[n]-type receptors in biomedical applications.

Notes and references

  • 1).a) Masson E, Ling X, Joseph R, Kyeremeh-Mensah L and Lu X, RSC Adv., 2012, 2, 1213–1247 [Google Scholar]; b) Barrow SJ, Kasera S, Rowland MJ, del Barrio J and Scherman OA, Chem. Rev, 2015, 115, 12320–12406 [DOI] [PubMed] [Google Scholar]; c) Shetty D, Khedkar JK, Park KM and Kim K, Chem. Soc. Rev, 2015, 44, 8747–8761 [DOI] [PubMed] [Google Scholar]; d) Ganapati S and Isaacs L, Isr. J. Chem, 2018, 58, 250–263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2).a) Mock WL and Shih N-Y, J. Org. Chem, 1986, 51, 4440–4446 [Google Scholar]; b) Liu S, Ruspic C, Mukhopadhyay P, Chakrabarti S, Zavalij PY and Isaacs L, J. Am. Chem. Soc, 2005, 127, 15959–15967 [DOI] [PubMed] [Google Scholar]; c) Rekharsky MV, Mori T, Yang C, Ko YH, Selvapalam N, Kim H, Sobransingh D, Kaifer AE, Liu S, Isaacs L, Chen W, Moghaddam S, Gilson MK, Kim K and Inoue Y, Proc. Natl. Acad. Sci. U. S. A, 2007, 104, 20737–20742 [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Moghaddam S, Yang C, Rekharsky M, Ko YH, Kim K, Inoue Y and Gilson MK, J. Am. Chem. Soc, 2011, 133, 3570–3581 [DOI] [PMC free article] [PubMed] [Google Scholar]; e) Cao L, Sekutor M, Zavalij PY, Mlinaric-Majerski K, Glaser R and Isaacs L, Angew. Chem. Int. Ed, 2014, 53, 988–993. [DOI] [PubMed] [Google Scholar]
  • 3).a) Biedermann F, Uzunova VD, Scherman OA, Nau WM and De Simone A, J. Am. Chem. Soc, 2012, 134, 15318–15323 [DOI] [PubMed] [Google Scholar]; b) Biedermann F, Nau WM and Schneider H-J, Angew. Chem. Int. Ed, 2014, 53, 11158–11171 [DOI] [PubMed] [Google Scholar]; c) Assaf KI and Nau WM, Chem. Soc. Rev, 2015, 44, 394–418. [DOI] [PubMed] [Google Scholar]
  • 4).a) Muddana HS, Daniel Varnado C, Bielawski CW, Urbach AR, Isaacs L, Geballe MT and Gilson MK, J. Comput.-Aided Mol. Des, 2012, 26, 475–487 [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Assaf KI, Florea M, Antony J, Henrikson NM, Yin J, Hansen A, Qu Z-W, Sure R, Klapstein D, Gilson MK, Grimme S and Nau WM, J. Phys. Chem. B, 2017, 121, 11144–11162 [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Rizzi A, Murkli S, McNeill JN, Yao W, Sullivan M, Gilson MK, Chiu MW, Isaacs L, Gibb BC, Mobley DL and Chodera JD, J. Comput.-Aided Mol. Des, 2018, 32, 937–963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5).a) Ko YH, Kim E, Hwang I and Kim K, Chem. Commun, 2007, 1305–1315 [DOI] [PubMed] [Google Scholar]; b) Saleh N, Koner AL and Nau WM, Angew. Chem. Int. Ed, 2008, 47, 5398–5401 [DOI] [PubMed] [Google Scholar]; c) Del Barrio J, Horton P, Lairez D, Lloyd G, Toprakcioglu C and Scherman O, J. Am. Chem. Soc, 2013, 135, 11760–11763 [DOI] [PubMed] [Google Scholar]; d) Isaacs L, Acc. Chem. Res, 2014, 47, 2052–2062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6).Ghale G and Nau WM, Acc. Chem. Res, 2014, 47, 2150–2159. [DOI] [PubMed] [Google Scholar]
  • 7).a) Yin H and Wang R, Isr. J. Chem, 2017, 58, 188–198 [Google Scholar]; b) Zhang X, Xu X, Li S, Li L, Zhang J and Wang R , Theranostics, 2019, 9, 633–645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8).Tian J, Xu Z-Y, Zhang D-W, Wang H, Xie S-H, Xu D-W, Ren Y-H, Wang H, Liu Y and Li Z-T, Nat. Commun, 2016, 7, 11580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9).a) Ahn Y, Jang Y, Selvapalam N, Yun G and Kim K, Angew. Chem. Int. Ed, 2013, 52, 3140–3144 [DOI] [PubMed] [Google Scholar]; b) Park KM, Murray J and Kim K, Acc. Chem. Res, 2017, 50, 644–646 [DOI] [PubMed] [Google Scholar]; c) Samanta SK, Quigley J, Vinciguerra B, Briken V and Isaacs L, J. Am. Chem. Soc, 2017, 139, 9066–9074 [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Sun C, Zhang H, Li S, Zhang X, Cheng Q, Ding Y, Wang L-H and Wang R, ACS Appl. Mater. Interfaces, 2018, 10, 25090–25098 [DOI] [PubMed] [Google Scholar]; e) Zhang S, Dominguez Z, Assaf KI, Nilam M, Thiele T, Pischel U, Schedler U, Nau WM and Hennig A, Chem. Sci, 2018, 9, 8575–8581 [DOI] [PMC free article] [PubMed] [Google Scholar]; f) Zou L, Braegelman AS and Webber MJ, ACS Cent. Sci, 2019, 5, 1035–1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10).a) Stancl M, Hodan M and Sindelar V, Org. Lett, 2009, 11, 4184–4187 [DOI] [PubMed] [Google Scholar]; b) Stancl M, Gilberg L, Ustrnul L, Necas M and Sindelar V, Supramol. Chem, 2014, 26, 168–172 [Google Scholar]; c) Bauer D, Andrae B, Gass P, Trenz D, Becker S and Kubik S, Org. Chem. Front, 2019, DOI: 10.1039/c9qo00156e, Ahead of Print [DOI] [Google Scholar]; d) Mao W, Mao D, Yang F and Ma D, Chem. - Eur. J, 2019, 25, 2272–2280. [DOI] [PubMed] [Google Scholar]
  • 11).a) Ma D, Hettiarachchi G, Nguyen D, Zhang B, Wittenberg JB, Zavalij PY, Briken V and Isaacs L, Nat. Chem, 2012, 4, 503–510 [DOI] [PubMed] [Google Scholar]; b) Hoffmann U, Grosse-Sundrup M, Eikermann-Haerter K, Zaremba S, Ayata C, Zhang B, Ma D, Isaacs L and Eikermann M, Anesthesiology, 2013, 119, 317–325 [DOI] [PubMed] [Google Scholar]; c) Haerter F, Simons JCP, Foerster U, Moreno Duarte I, Diaz-Gil D, Ganapati S, Eikermann-Haerter K, Ayata C, Zhang B, Blobner M, Isaacs L and Eikermann M, Anesthesiology, 2015, 123, 1337–1349 [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Diaz-Gil D, Haerter F, Falcinelli S, Ganapati S, Hettiarachchi GK, Simons JCP, Zhang B, Grabitz SD, Duarte IM, Cotten JF, Eikermann-Haerter K, Deng H, Chamberlin NL, Isaacs L, Briken V and Eikermann M, Anesthesiology, 2016, 125, 333–345 [DOI] [PMC free article] [PubMed] [Google Scholar]; e) Hettiarachchi G, Samanta SK, Falcinelli S, Zhang B, Moncelet D, Isaacs L and Briken V, Mol. Pharmaceutics, 2016, 13, 809–818 [DOI] [PMC free article] [PubMed] [Google Scholar]; f) Sigwalt D, Moncelet D, Falcinelli S, Mandadapu V, Zavalij PY, Day A, Briken V and Isaacs L, ChemMedChem, 2016, 11, 980–989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12).Zhang B and Isaacs L, J. Med. Chem, 2014, 57, 9554–9563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13).Mao D, Liang Y, Liu Y, Zhou X, Ma J, Jiang B, Liu J and Ma D, Angew. Chem. Int. Ed, 2017, 41, 12614–12618. [DOI] [PubMed] [Google Scholar]
  • 14).a) Ma D, Zhang B, Hoffmann U, Sundrup MG, Eikermann M and Isaacs L, Angew. Chem. Int. Ed, 2012, 51, 11358–11362 [DOI] [PubMed] [Google Scholar]; b) Ganapati S, Grabitz SD, Murkli S, Scheffenbichler F, Rudolph MI, Zavalij PY, Eikermann M and Isaacs L, ChemBioChem, 2017, 18, 1583–1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15).Shcherbakova EG, Zhang B, Gozem S, Minami T, Zavalij Peter Y, Pushina M, Isaacs L and Anzenbacher PJ, J. Am. Chem. Soc, 2017, 139, 14954–14960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16).a) Liu W, Lu X, Meng Z and Isaacs L, Org. Biomol. Chem, 2018, 16, 6499–6506 [DOI] [PubMed] [Google Scholar]; b) Liu W, Lu X, Xue W, Samanta SK, Zavalij PY, Meng Z and Isaacs L, Chem. - Eur. J, 2018, 24, 14101–14110 [DOI] [PubMed] [Google Scholar]; c) Lu X, Samanta SK, Zavalij PY and Isaacs L, Angew. Chem., Int. Ed, 2018, 57, 8073–8078. [DOI] [PubMed] [Google Scholar]
  • 17).Isaacs L, The SAMPL7 Blind Prediction Challenges for Computational Chemistry, https://github.com/MobleyLab/SAMPL7, Accessed September 27, 2019. [Google Scholar]
  • 18).Gilberg L, Zhang B, Zavalij PY, Sindelar V and Isaacs L, Org. Biomol. Chem, 2015, 13, 4041–4050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19).Diederich F, Angew. Chem., Intl. Ed. Engl, 1988, 27, 362–386. [Google Scholar]
  • 20).Zhang B, Zavalij PY and Isaacs L, Org. Biomol. Chem, 2014, 12, 2413–2422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21).a) Wiseman T, Williston S, Brandts JF and Lin L-N, Anal. Biochem, 1989, 179, 131–137 [DOI] [PubMed] [Google Scholar]; b) Broecker J, Vargas C and Keller S, Anal. Biochem, 2011, 418, 307–309. [DOI] [PubMed] [Google Scholar]
  • 22).Xue W, Zavalij PY and Isaacs L, Org. Biomol. Chem, 2019, 17, 5561–5569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23).Ma D, Zavalij PY and Isaacs L, J. Org. Chem, 2010, 75, 4786–4795. [DOI] [PubMed] [Google Scholar]
  • 24).a) Shaikh M, Mohanty J, Singh P, Nau W and Pal H, Photochem. Photobiol. Sci, 2008, 7, 408–414 [DOI] [PubMed] [Google Scholar]; b) Ghosh I and Nau WM, Adv. Drug Delivery Rev, 2012, 64, 764–783. [DOI] [PubMed] [Google Scholar]
  • 25).Masson E, Shaker YM, Masson J-P, Kordesch ME and Yuwono C, Org. Lett, 2011, 13, 3872–3875. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES